Pharmabiz

Actimed Therapeutics receives Japanese patent for new composition of matter patent for S-pindolol benzoate

Actimed Therapeutics receives Japanese patent for new composition of matter patent for S-pindolol benzoate: London, UK Tuesday, November 4, 2025, 16:00 Hrs [IST] Actimed Therapeut ...

Actimed Therapeutics Further Expands Intellectual Property Portfolio for Lead Compound with New Composition of Matter Patent in Japan

Patent expands IP protection for S-pindolol benzoate (ACM-001.1), reinforcing the global IP position of Actimed with granted patents in all key markets London, UK – 3 November 2025. Actimed ...
WIVB-TV

Actimed Therapeutics Announces New Programme to Investigate Potential Muscle Preservation Effects of S-pindolol Benzoate in Obese Patients Treated with GLP-1 Agonists

Two-part preclincal and clinical development programme launched to assess potential benefits of administering S-pindolol benzoate during and post-GLP-1 receptor agonist therapy to improve muscle mass, ...
FierceBiotech

PsiOxus Therapeutics Initiates Phase II Clinical Study of Wasting Disease Therapeutic MT-102

LONDON--(BUSINESS WIRE)-- PsiOxus Therapeutics, Ltd. (PsiOxus) announced initiation of a Phase II study of MT-102, a small molecule therapeutic for the treatment of cancer- and age-related wasting. MT ...
Post Register

US Olympic sprinter Knighton banned for positive test for anabolic steroid

GENEVA (AP) — Two-time Olympic finalist Erriyon Knighton was banned for four years on Friday in a doping case that ruled the 21-year-old United States sprinter out of the 2028 Los Angeles Games. The ...